Found 2 results
Filters: Keyword is Half-Life  [Clear All Filters]
2017
K Min C, Lasseter KC, Marbury TC, Wrishko RE, Hanley WD, Wolford DG, de Haes JUdo, Reitmann C, Gutstein DE.  2017.  Pharmacokinetics of sugammadex in subjects with moderate and severe renal impairment
.. Int J Clin Pharmacol Ther. 55(9):746-752.
2015
Zhu EF, Gai SA, Opel CF, Kwan BH, Surana R, Mihm MC, Kauke MJ, Moynihan KD, Angelini A, Williams RT et al..  2015.  Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2.. Cancer Cell. 27(4):489-501.